Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185HER2/neu protein expression in breast cancer drill biopsies

This publication has 21 references indexed in Scilit:

• Should Selection of Adjuvant Chemotherapy for Patients With Breast Cancer Be Based on erbB-2 Status?
  JNCI Journal of the National Cancer Institute, 1998
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
  Journal of Clinical Oncology, 1998
• neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.
  Journal of Clinical Oncology, 1998
• Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
  Journal of Clinical Oncology, 1997
• Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
  British Journal of Cancer, 1995
• Determination of Gene Dosage by a Quantitative Adaptation of the Polymerase Chain Reaction (gd-PCR): Rapid Detection of Deletions and Duplications of Gene Sequences
  Genomics, 1994
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
  Proceedings of the National Academy of Sciences, 1994
• Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
  Journal of Clinical Oncology, 1992
• HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
  Journal of Clinical Oncology, 1992
• Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by aPCR aidedtranscipttitration assay (PATTY)
  Nucleic Acids Research, 1989